Philadelphia, Pennsylvania, United States
Contact Info
3K followers
500+ connections
About
Clinical Research
Gene Therapy
Rare Diseases
Activity
-
More good news about the future ALZpath Inc. is charting in support of #AlzheimersAwareness and #MedicalDiagnostics
More good news about the future ALZpath Inc. is charting in support of #AlzheimersAwareness and #MedicalDiagnostics
Liked by Steven Zelenkofske
-
🎉 The BioHub Episode 7 is Now Live! 🎉 We’re thrilled to present an exclusive episode featuring David J. Mazzo, Ph.D., CEO of Lisata Therapeutics…
🎉 The BioHub Episode 7 is Now Live! 🎉 We’re thrilled to present an exclusive episode featuring David J. Mazzo, Ph.D., CEO of Lisata Therapeutics…
Liked by Steven Zelenkofske
-
ALZpath Inc. is thrilled to announce its attendance at the Alzheimer's Association International Conference (AAIC) #AAIC2024 in Philadelphia, USA…
ALZpath Inc. is thrilled to announce its attendance at the Alzheimer's Association International Conference (AAIC) #AAIC2024 in Philadelphia, USA…
Liked by Steven Zelenkofske
Experience & Education
Publications
-
Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
We sought to determine the feasibility of conducting percutaneous coronary intervention (PCI) in high-risk acute coronary syndrome (ACS) patients utilising the REG1 system consisting of pegnivacogin, an aptameric factor IXa inhibitor, and its controlling agent anivamersen.
More activity by Steven
-
We are proud to share the exceptional progress of 2022 Termeer Fellow, Yael Weiss, CEO of Mahzi Therapeutics. Under her leadership, Mahzi has been…
We are proud to share the exceptional progress of 2022 Termeer Fellow, Yael Weiss, CEO of Mahzi Therapeutics. Under her leadership, Mahzi has been…
Liked by Steven Zelenkofske
-
We are thrilled to share that ALZpath Inc. has signed a licensing agreement with Beckman Coulter Diagnostics to leverage our proprietary #pTau217…
We are thrilled to share that ALZpath Inc. has signed a licensing agreement with Beckman Coulter Diagnostics to leverage our proprietary #pTau217…
Liked by Steven Zelenkofske
-
Inspiring conversations yesterday at the JPMorganChase 60 years Swizerland celebrations in Zurich- Thanks for inviting me. AI & Biology: “Your…
Inspiring conversations yesterday at the JPMorganChase 60 years Swizerland celebrations in Zurich- Thanks for inviting me. AI & Biology: “Your…
Liked by Steven Zelenkofske
-
I am deeply honored to join the talented team at ALZpath Inc. and look forward to working closely with our current and future partners to help usher…
I am deeply honored to join the talented team at ALZpath Inc. and look forward to working closely with our current and future partners to help usher…
Liked by Steven Zelenkofske
-
Meet Dr. Aaron Cohen-Gadol, neurosurgeon with Keck Medicine of USC who specializes in performing complex brain procedures. Dr. Cohen's focus is on…
Meet Dr. Aaron Cohen-Gadol, neurosurgeon with Keck Medicine of USC who specializes in performing complex brain procedures. Dr. Cohen's focus is on…
Liked by Steven Zelenkofske
-
"Shalom + Peace for all" - sign against anti-Semitism and for cohesion as well as "a day with Jewish music". At the Römisch-Germanisches Museum…
"Shalom + Peace for all" - sign against anti-Semitism and for cohesion as well as "a day with Jewish music". At the Römisch-Germanisches Museum…
Liked by Steven Zelenkofske
-
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) lead candidate tecarfarin, a next-generation Vitamin K antagonist (VKA), recently received FDA Orphan Drug…
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) lead candidate tecarfarin, a next-generation Vitamin K antagonist (VKA), recently received FDA Orphan Drug…
Liked by Steven Zelenkofske
-
Great news that The Danish Government has agreed on a new package that removes two taxes on entrepreneurship and increase the incentive for Danish…
Great news that The Danish Government has agreed on a new package that removes two taxes on entrepreneurship and increase the incentive for Danish…
Liked by Steven Zelenkofske
-
Jeff Cole, Chief Commercial Officer of Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), attended the BIO International Conference last week in San Diego…
Jeff Cole, Chief Commercial Officer of Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), attended the BIO International Conference last week in San Diego…
Liked by Steven Zelenkofske
-
Our licensing agreement with Roche Diagnostics USA for use of our proprietary #pTau217 antibody in its blood test will pave the way to diagnose…
Our licensing agreement with Roche Diagnostics USA for use of our proprietary #pTau217 antibody in its blood test will pave the way to diagnose…
Liked by Steven Zelenkofske
-
Some happy personal news! I was on the West Coast the last week of May celebrating our youngest daughter's wedding. It was a special moment for…
Some happy personal news! I was on the West Coast the last week of May celebrating our youngest daughter's wedding. It was a special moment for…
Liked by Steven Zelenkofske
Other similar profiles
-
Raul Lima
Connect -
Chris Rusconi
Connect -
Iman El-Hariry
Connect -
Gen Li, PhD, MBA
Connect -
Audrey Rossow
Connect -
Sophia Davis
Seasoned Biotech Executive Search Professional Focused on Chief Medical Officer and Board Member Roles
Connect -
Deyaa Adib, MD
Connect -
Yaping Shou
Connect -
Mustafa A. Noor, MD, FACP
Connect -
Manfred Stapff, MD, PhD
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More